Literature DB >> 29594807

Genetic Polymorphisms in miR-146a, miR-196a2 and miR-125a Genes and its Association in Prostate Cancer.

Mohan Damodaran1, Solomon F D Paul1, Vettriselvi Venkatesan2.   

Abstract

The increase in incidence of prostate cancer in the Indian Population stresses the need to identify genetic markers for susceptibility and prognosis. Recent studies show that microRNAs play an important role in tumorigenesis by altering proliferation, differentiation and cell death. Gene polymorphisms not only in promoter region but also within miRNA gene have been shown to affect expression. The present study was aimed to analyze the role of miR-146a, miR-196a2 and miR-125a gene polymorphisms in prostate cancer. Genotyping of three SNPs rs73318382, rs57095329, rs2910164 in miRNA146a, rs11614913 in miR-196a2 and rs41275794, rs12976445, rs10404453 and rs1297533 in miR-125a was performed in 100 cases and 100 controls. Statistical analysis revealed the heterozygous AG genotype of the rs57095329 was significantly decreased in the cases when compared to the controls (OR-0.45, CI -0.24 to 0.85, p value-0.02) indicating an inverse association of this genotype with prostate cancer. Further the heterozygous CT of miR-196a2 (rs11614913) (OR-1.88, CI-1.06 to 3.35, p-0.02) and homozygous CC of miR-125a (rs12976445) (OR-2.55, CI -1.15 to 4.65, p-0.03) showed increased risk for prostate cancer. Combined analysis of all the genotypes revealed that the haplotype combination AGGCGTGG (OR = 0.09 at CI 95% (0.01-0.65) showed an inverse association with prostate cancer. Stratified analysis based on the age and tumor grade revealed no significant association.

Entities:  

Keywords:  Genotyping; Haplotypes; Prostate cancer; microRNA

Mesh:

Substances:

Year:  2018        PMID: 29594807     DOI: 10.1007/s12253-018-0412-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  31 in total

1.  Identification of novel genes coding for small expressed RNAs.

Authors:  M Lagos-Quintana; R Rauhut; W Lendeckel; T Tuschl
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

2.  MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer.

Authors:  Bin Xu; Ning Wang; Xuhui Wang; Na Tong; Ning Shao; Jun Tao; Pengchao Li; Xiaobing Niu; Ninghan Feng; Lihua Zhang; Lixin Hua; Zengjun Wang; Ming Chen
Journal:  Prostate       Date:  2011-12-07       Impact factor: 4.104

3.  Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.

Authors:  Gary K Scott; Andrei Goga; Dipa Bhaumik; Crystal E Berger; Christopher S Sullivan; Christopher C Benz
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

4.  A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population.

Authors:  Lingjun Zhu; Haiyan Chu; Dongying Gu; Lan Ma; Danni Shi; Dongyan Zhong; Na Tong; Zhengdong Zhang; Meilin Wang
Journal:  DNA Cell Biol       Date:  2011-08-04       Impact factor: 3.311

5.  Genetic variation in microRNA genes and prostate cancer risk in North Indian population.

Authors:  Ginu P George; Ruchika Gangwar; Raju K Mandal; Satya N Sankhwar; Rama D Mittal
Journal:  Mol Biol Rep       Date:  2010-09-15       Impact factor: 2.316

6.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

7.  A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer.

Authors:  Yee Soo Chae; Jong Gwang Kim; Soo Jung Lee; Byung Woog Kang; Yoo Jin Lee; Jae Yong Park; Hyo-Sung Jeon; Jun Seok Park; Gyu Seog Choi
Journal:  Anticancer Res       Date:  2013-08       Impact factor: 2.480

8.  A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.

Authors:  Xiaobing Luo; Wanling Yang; Dong-Qing Ye; Huijuan Cui; Yan Zhang; Nattiya Hirankarn; Xiaoxia Qian; Yuanjia Tang; Yu Lung Lau; Niek de Vries; Paul Peter Tak; Betty P Tsao; Nan Shen
Journal:  PLoS Genet       Date:  2011-06-30       Impact factor: 5.917

Review 9.  OncomiRs: the discovery and progress of microRNAs in cancers.

Authors:  William C S Cho
Journal:  Mol Cancer       Date:  2007-09-25       Impact factor: 27.401

10.  Common SNP in hsa-miR-196a-2 increases hsa-miR-196a-5p expression and predisposes to idiopathic male infertility in Chinese Han population.

Authors:  Jing Lu; Hao Gu; Qiuqin Tang; Wei Wu; Beilei Yuan; Dan Guo; Yongyue Wei; Hong Sun; Yankai Xia; Hongjuan Ding; Lingqing Hu; Daozhen Chen; Jiahao Sha; Xinru Wang
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379

View more
  5 in total

1.  Differentially expressed miR-20, miR-21, miR-100, miR-125a and miR-146a as a potential biomarker for prostate cancer.

Authors:  Mohan Damodaran; Mohanapriya Chinambedu Dandapani; S VenkatRamanan; Ilangovan Ramachandran; Vettriselvi Venkatesan
Journal:  Mol Biol Rep       Date:  2021-05-04       Impact factor: 2.316

2.  Association between risk of brucellosis and genetic variations in MicroRNA-146a.

Authors:  Sima Kazemi; Saeid Afshar; Manoochehr Karami; Massoud Saidijam; Fariba Keramat; Seyed Hamid Hashemi; Mohammad Yousef Alikhani
Journal:  BMC Infect Dis       Date:  2021-10-16       Impact factor: 3.090

3.  Effect of miR-196a2 rs11614913 Polymorphism on Cancer Susceptibility: Evidence From an Updated Meta-Analysis.

Authors:  Md Abdul Aziz; Tahmina Akter; Mohammad Safiqul Islam
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

4.  Curcumol Inhibits the Development of Prostate Cancer by miR-125a/STAT3 Axis.

Authors:  Wen Sheng; Jin Ding; Lumei Liu; Neng Wang; Baowei Lu; Xujun You; Qinghu He; Qing Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-30       Impact factor: 2.650

Review 5.  Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Authors:  Arsinoe C Thomaidou; Panagiota Batsaki; Maria Adamaki; Maria Goulielmaki; Constantin N Baxevanis; Vassilis Zoumpourlis; Sotirios P Fortis
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.